Breakthrough atypical mpox in a vaccinated individual with high antibody titres
- PMID: 40541305
- DOI: 10.1016/S1473-3099(25)00220-8
Breakthrough atypical mpox in a vaccinated individual with high antibody titres
Conflict of interest statement
Declaration of interests JB has received honoraria from AstraZeneca and travel grants from Gilead Sciences, ViiV Healthcare, and GlaxoSmithKline. CO’B has been awarded grants from Abbott, received honoraria from GlaxoSmithKline, and has given clinical consultation for Gilead Sciences. PWGM has received honoraria from Janssen Cilag, Gilead Sciences, and MSD; travel grants from AstraZeneca; is a member of advisory boards for AstraZeneca and ViiV Healthcare; and has been awarded grants from Gilead Sciences and GlaxoSmithKline outside the submitted work. All other authors declare no competing interests.
LinkOut - more resources
Full Text Sources